Identification of a methylated oligoribonucleotide as a potent inhibitor of HIV-1 reverse transcription complex

Nucleic Acids Research

Volumn 39, Issue 13, 2011, Pages 5586-5596

  Grigorov, Boyan ^a   Bocquin, Anne ^a   Gabus, Caroline ^a   Avilov, Sergey ^b,c   Mély, Yves ^b   Agopian, Audrey ^d   Divita, Gilles ^d   Gottikh, Marina ^e   Witvrouw, Myriam ^f   Darlix, Jean Luc ^a  

^a UNIVERSITÉ DE LYON   (France)

^b Faculté de Pharmacie   (France)

^c Palladin Institute   (Ukraine)

^d Centre National de la Recherche Scientifique   (France)

^e MOSCOW STATE UNIVERSITY   (Russian Federation)

^f UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PENETRATING PEPTIDE; COMPLEMENTARY DNA; EFAVIRENZ; METHYLATED OLIGORIBONUCLEOTIDE; NEVIRAPINE; NUCLEOCAPSID PROTEIN; OLIGORIBONUCLEOTIDE; RALTEGRAVIR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; UNCLASSIFIED DRUG; ZIDOVUDINE;

ANTIVIRAL RESISTANCE; ARTICLE; CELL CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA SYNTHESIS INHIBITION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; INHIBITION KINETICS; MOLECULAR CLONING; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIRUS INHIBITION; VIRUS REPLICATION;

ANTI-HIV AGENTS; CELLS, CULTURED; DNA, COMPLEMENTARY; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV REVERSE TRANSCRIPTASE; HIV-1; HUMANS; METHYLATION; MUTATION; OLIGORIBONUCLEOTIDES; REVERSE TRANSCRIPTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80051775097     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkr117     Document Type: Article

References (48)

1. Chertova, E., Chertov, O., Coren, L.V., Roser, J.D., Trubey, C.M., Bess, J.W., Sowder, R.C., Barsov, E., Hood, B.L., Fisher, R.J. et al. (2006) Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages. J. Virol., 80, 9039-9052. (Pubitemid 44359978)
2. Iordanskiy, S.N. and Bukrinsky, M.I. (2009) Analysis of viral and cellular proteins in HIV-1 reverse transcription complexes by co-immunoprecipitation. Methods Mol. Biol., 485, 121-134.
3. Darlix, J., Garrido, J.L., Morellet, N., Mely, Y. and de Rocquigny, H. (2007) Properties, functions, and drug targeting of the multifunctional nucleocapsid protein of the human immunodeficiency virus. Adv. Pharmacol., 55, 299-346.
4. Darlix, J.L., Lapadat-Tapolsky, M., de Rocquigny, H. and Roques, B.P. (1995) First glimpses at structure-function relationships of the nucleocapsid protein of retroviruses. J. Mol. Biol., 254, 523-537. (Pubitemid 26001788)
5. Levin, J.G., Guo, J., Rouzina, I. and Musier-Forsyth, K. (2005) Nucleic acid chaperone activity of HIV-1 nucleocapsid protein: critical role in reverse transcription and molecular mechanism. Prog. Nucleic Acid Res. Mol. Biol., 80, 217-286. (Pubitemid 43574891)
6. Mougel, M., Houzet, L. and Darlix, J. (2009) When is it time for reverse transcription to start and go? Retrovirology, 6, 24.
7. Thomas, J.A. and Gorelick, R.J. (2008) Nucleocapsid protein function in early infection processes. Virus Res., 134, 39-63.
8. Rein, A., Henderson, L.E. and Levin, J.G. (1998) Nucleic-acid-chaperone activity of retroviral nucleocapsid proteins: significance for viral replication. Trends Biochem. Sci., 23, 297-301. (Pubitemid 28461895)
9. Levin, J.G., Mitra, M., Mascarenhas, A. and Musier-Forsyth, K. (2010) Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription. RNA Biol., 7, 754-774.
10. Grigorov, B., Decimo, D., Smagulova, F., Pechoux, C., Mougel, M., Muriaux, D. and Darlix, J. (2007) Intracellular HIV-1 Gag localization is impaired by mutations in the nucleocapsid zinc fingers. Retrovirology, 4, 54.
11. D'Souza, V. and Summers, M.F. (2005) How retroviruses select their genomes. Nat. Rev. Microbiol., 3, 643-655. (Pubitemid 41052151)
12. Goldschmidt, V., Miller Jenkins, L.M., de Rocquigny, H., Darlix, J. and Mely, Y. (2010) The nucleocapsid protein of HIV-1 as a promising therapeutic target for antiviral drugs. HIV Therapy, 4, 179-198.
13. de Rocquigny, H., Shvadchak, V., Avilov, S., Dong, C.Z., Dietrich, U., Darlix, J. and Mely, Y. (2008) Targeting the viral nucleocapsid protein in anti-HIV-1 therapy. Mini Rev. Med. Chem., 8, 24-35. (Pubitemid 351320927)
14. Morris, M.C., Chaloin, L., Choob, M., Archdeacon, J., Heitz, F. and Divita, G. (2004) Combination of a new generation of PNAs with a peptide-based carrier enables efficient targeting of cell cycle progression. Gene Ther., 11, 757-764. (Pubitemid 38659754)
15. Morris, M.C., Gros, E., Aldrian-Herrada, G., Choob, M., Archdeacon, J., Heitz, F. and Divita, G. (2007) A non-covalent peptide-based carrier for in vivo delivery of DNA mimics. Nucleic Acids Res., 35, e49.
16. Crombez, L., Morris, M.C., Deshayes, S., Heitz, F. and Divita, G. (2008) Peptide-based nanoparticle for ex vivo and in vivo drug delivery. Curr. Pharm. Des., 14, 3656-3665.
17. Morris, M.C., Deshayes, S., Heitz, F. and Divita, G. (2008) Cell-penetrating peptides: from molecular mechanisms to therapeutics. Biol. Cell, 100, 201-217. (Pubitemid 351517084)
18. Kuciak, M., Gabus, C., Ivanyi-Nagy, R., Semrad, K., Storchak, R., Chaloin, O., Muller, S., Mely, Y. and Darlix, J. (2008) The HIV-1 transcriptional activator Tat has potent nucleic acid chaperoning activities in vitro. Nucleic Acids Res., 36, 3389-3400. (Pubitemid 351859006)
19. Ivanyi-Nagy, R., Lavergne, J., Gabus, C., Ficheux, D. and Darlix, J. (2008) RNA chaperoning and intrinsic disorder in the core proteins of Flaviviridae. Nucleic Acids Res., 36, 712-725. (Pubitemid 351267229)
20. Ali, M.B., Chaminade, F., Kanevsky, I., Ennifar, E., Josset, L., Ficheux, D., Darlix, J. and Fosse, P. (2007) Structural requirements for nucleocapsid protein-mediated dimerization of avian leukosis virus RNA. J. Mol. Biol., 372, 1082-1096. (Pubitemid 47368353)
21. De Rocquigny, H., Gabus, C., Vincent, A., Fournie-Zaluski, M.C., Roques, B. and Darlix, J.L. (1992) Viral RNA annealing activities of human immunodeficiency virus type 1 nucleocapsid protein require only peptide domains outside the zinc fingers. Proc. Natl Acad. Sci. USA, 89, 6472-6476.
22. Moscardini, M., Pistello, M., Bendinelli, M., Ficheux, D., Miller, J.T., Gabus, C., Le Grice, S.F.J., Surewicz, W.K. and Darlix, J. (2002) Functional interactions of nucleocapsid protein of feline immunodeficiency virus and cellular prion protein with the viral RNA. J. Mol. Biol., 318, 149-159. (Pubitemid 34729392)
23. Goujon, C., Riviè re, L., Jarrosson-Wuilleme, L., Bernaud, J., Rigal, D., Darlix, J. and Cimarelli, A. (2007) SIVSM/HIV-2 Vpx proteins promote retroviral escape from a proteasome-dependent restriction pathway present in human dendritic cells. Retrovirology, 4, 2.
24. Jarrosson-Wuilleme, L., Goujon, C., Bernaud, J., Rigal, D., Darlix, J. and Cimarelli, A. (2006) Transduction of nondividing human macrophages with gammaretrovirus-derived vectors. J. Virol., 80, 1152-1159. (Pubitemid 43134072)
25. Arfi, V., Lienard, J., Nguyen, X., Berger, G., Rigal, D., Darlix, J. and Cimarelli, A. (2009) Characterization of the behavior of functional viral genomes during the early steps of human immunodeficiency virus type 1 infection. J. Virol., 83, 7524-7535.
26. Grigorov, B., Arcanger, F., Roingeard, P., Darlix, J. and Muriaux, D. (2006) Assembly of infectious HIV-1 in human epithelial and T-lymphoblastic cell lines. J. Mol. Biol., 359, 848-862. (Pubitemid 43842051)
27. Grigorov, B., Attuil-Audenis, V., Perugi, F., Nedelec, M., Watson, S., Pique, C., Darlix, J., Conjeaud, H. and Muriaux, D. (2009) A role for CD81 on the late steps of HIV-1 replication in a chronically infected T cell line. Retrovirology, 6, 28.
28. Godet, J., de Rocquigny, H., Raja, C., Glasser, N., Ficheux, D., Darlix, J. and Mely, Y. (2006) During the early phase of HIV-1 DNA synthesis, nucleocapsid protein directs hybridization of the TAR complementary sequences via the ends of their double-stranded stem. J. Mol. Biol., 356, 1180-1192. (Pubitemid 43199922)
29. Nijhuis, M., van Maarseveen, N.M., Lastere, S., Schipper, P., Coakley, E., Glass, B., Rovenska, M., de Jong, D., Chappey, C., Goedegebuure, I.W. et al. (2007) A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism. PLoS Med., 4, e36.
30. Mikaelian, I. and Sergeant, A. (1992) A general and fast method to generate multiple site directed mutations. Nucleic Acids Res., 20, 376.
31. Berglund, J.A., Charpentier, B. and Rosbash, M. (1997) A high affinity binding site for the HIV-1 nucleocapsid protein. Nucleic Acids Res., 25, 1042-1049. (Pubitemid 27298275)
32. Avilov, S.V., Godet, J., Piemont, E. and Mely, Y. (2009) Site-specific characterization of HIV-1 nucleocapsid protein binding to oligonucleotides with two binding sites. Biochemistry, 48, 2422-2430.
33. Fisher, R.J., Rein, A., Fivash, M., Urbaneja, M.A., Casas-Finet, J.R., Medaglia, M. and Henderson, L.E. (1998) Sequence-specific binding of human immunodeficiency virus type 1 nucleocapsid protein to short oligonucleotides. J. Virol., 72, 1902-1909. (Pubitemid 28100742)
34. Vuilleumier, C., Bombarda, E., Morellet, N., Gerard, D., Roques, B.P. and Mely, Y. (1999) Nucleic acid sequence discrimination by the HIV-1 nucleocapsid protein NCp7: a fluorescence study. Biochemistry, 38, 16816-16825.
35. Roda, R.H., Balakrishnan, M., Hanson, M.N., Wohrl, B.M., Le Grice, S.F.J., Roques, B.P., Gorelick, R.J. and Bambara, R.A. (2003) Role of the reverse transcriptase, nucleocapsid protein, and template structure in the two-step transfer mechanism in retroviral recombination. J. Biol. Chem., 278, 31536-31546. (Pubitemid 37048331)
36. Vo, M., Barany, G., Rouzina, I. and Musier-Forsyth, K. (2009) HIV-1 nucleocapsid protein switches the pathway of transactivation response element RNA/DNA annealing from loop-loop "kissing" to "zipper". J. Mol. Biol., 386, 789-801.
37. Lapadat-Tapolsky, M., Gabus, C., Rau, M. and Darlix, J.L. (1997) Possible roles of HIV-1 nucleocapsid protein in the specificity of proviral DNA synthesis and in its variability. J. Mol. Biol., 268, 250-260. (Pubitemid 27208052)
38. Hombrouck, A., Van Remoortel, B., Michiels, M., Noppe, W., Christ, F., Eneroth, A., Sahlberg, B.L., Benkestock, K., Vrang, L., Johansson, N.G. et al. (2008) Preclinical evaluation of 1H-benzylindole derivatives as novel human immunodeficiency virus integrase strand transfer inhibitors. Antimicrob. Agents Chemother., 52, 2861-2869.
39. Ventura, M., Tarrago-Litvak, L., Dolle , V., Nguyen, C.H., Legraverend, M., Fleury, H.J. and Litvak, S. (1999) Effect of nucleoside analogs and non-nucleoside inhibitors of HIV-1 reverse transcriptase on cell-free virions. Arch. Virol., 144, 513-523. (Pubitemid 29172705)
40. Joly, V., Descamps, D., Peytavin, G., Touati, F., Mentre, F., Duval, X., Delarue, S., Yeni, P. and Brun-Vezinet, F. (2004) Evolution of human immunodeficiency virus type 1 (HIV-1) resistance mutations in nonnucleoside reverse transcriptase inhibitors (NNRTIs) in HIV-1-infected patients switched to antiretroviral therapy without NNRTIs. Antimicrob. Agents Chemother., 48, 172-175. (Pubitemid 38040194)
41. Bacheler, L.T., Anton, E.D., Kudish, P., Baker, D., Bunville, J., Krakowski, K., Bolling, L., Aujay, M., Wang, X.V., Ellis, D. et al. (2000) Human immunodeficiency virus type 1 mutations selected in patients failing efavirenz combination therapy. Antimicrob. Agents Chemother., 44, 2475-2484. (Pubitemid 30650898)
42. Das, K., Bauman, J.D., Clark, A.D., Frenkel, Y.V., Lewi, P.J., Shatkin, A.J., Hughes, S.H. and Arnold, E. (2008) High-resolution structures of HIV-1 reverse transcriptase/TMC278 complexes: strategic flexibility explains potency against resistance mutations. Proc. Natl Acad. Sci. USA, 105, 1466-1471. (Pubitemid 351346537)
43. Martinez-Picado, J. and Martnez, M.A. (2008) HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo. Virus Res., 134, 104-123.
44. Buckman, J.S., Bosche, W.J. and Gorelick, R.J. (2003) Human immunodeficiency virus type 1 nucleocapsid zn(2+) fingers are required for efficient reverse transcription, initial integration processes, and protection of newly synthesized viral DNA. J. Virol., 77, 1469-1480. (Pubitemid 36055568)
45. Grohmann, D., Godet, J., Mely, Y., Darlix, J. and Restle, T. (2008) HIV-1 nucleocapsid traps reverse transcriptase on nucleic acid substrates. Biochemistry, 47, 12230-12240.
46. Lener, D., Tanchou, V., Roques, B.P., Le Grice, S.F. and Darlix, J.L. (1998) Involvement of HIV-I nucleocapsid protein in the recruitment of reverse transcriptase into nucleoprotein complexes formed in vitro. J. Biol. Chem., 273, 33781-33786. (Pubitemid 29005769)
47. Sarafianos, S.G., Marchand, B., Das, K., Himmel, D.M., Parniak, M.A., Hughes, S.H. and Arnold, E. (2009) Structure and function of HIV-1 reverse transcriptase: molecular mechanisms of polymerization and inhibition. J. Mol. Biol., 385, 693-713.
48. Gotte, M., Rausch, J.W., Marchand, B., Sarafianos, S. and Le Grice, S.F.J. (2010) Reverse transcriptase in motion: conformational dynamics of enzyme-substrate interactions. Biochim. Biophys. Acta, 1804, 1202-1212.